Millions Logo
home>Stocks>Sai Life Sciences
Sai Life Sciences
Sai Life SciencesHealthcare
1,747.40+875.45 (+100.40%)in 1 year
As on 17 Nov 2026 at 14:55
Start SIP
52 Week Low: 783.8552 Week High: 1,954.80

Sai Life Sciences Share Price Today

Sai Life Sciences opened lower at ₹1,795.00, compared with its previous close of ₹1,800.20. During today's session, the stock has traded between ₹1,738.00 and ₹1,815.00, with an average traded price of ₹1,769.63. It is currently showing a downward intraday trend.

Return calculator

Time Period

An investment of ₹10,000 made 2 years ago in Sai Life Sciences is now worth

₹ 22,852.00

Giving a profit of

₹ 12,852.00 (128.52%)

Invest now

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating by Refinitive from 5 Analysts

Buy
100%
Hold
0%
Sell
0%

Markets Today

Today's Change

-52.80 (-2.93%)

Day High

₹1,815.00

Day Low

₹1,738.00

Day Open

₹1,795.00

Prev Close

₹1,800.20

Volume

15,02,057

Value Traded

₹265.81 Cr

1W Return

-4.87%

1M Return

25.77%

3M Return

20.52%

6M Return

60.18%

1Y Return

100.40%

Fundamentals

Market Cap (₹ Cr.)

37,114

PE Ratio

101.70

PB Ratio

14.23

Dividend Yield

-

ROE

14.05%

ROCE

18.10%

Book Value (₹)

126.45

Face Value (₹)

1.00

EPS (TTM)

4.63

Industry PE

-

Beta

-

Debt to Equity

-

Investment Returns

1 Week

-4.87%

6 Weeks

-

1 Month

25.77%

3 Months

20.52%

9 Months

89.80%

Financials

Yearly
Consolidated
All values in ₹ crores
7.87

Mar 21
8.98

Mar 22
12.45

Mar 23
14.94

Mar 24
17.31

Mar 25
22.42

Mar 26

Share Holding Pattern

Promoter34.50%
FII19.91%
DII32.32%
Retails & Others7.21%

Updates

12Nov

Sai Life Sciences Q2FY27 Results: Revenue up 23% YoY, capex plan intact

Consolidated revenue grew 23% YoY to ₹659 crore in Q2FY27, with CRO growing 28% and CDMO 20%. Net profit rose 17.3% YoY to ₹98 crore, while EBITDA margin held steady at 28%. Company commenced operations with first end-to-end integrated collaboration and converted another large pharma deal. Capex of ₹621 crore incurred in H1FY27; full-year plan of ₹1,100–1,300 crore remains intact. New Bidar capacity ready; additional 225 KL capacity delayed to early Q3FY28 without impacting FY28 revenue.

5 days ago
11Nov

Sai Life Sciences latest guidance: 15-18% revenue CAGR, 28-30% margin

Sai Life Sciences has issued medium-term guidance for a revenue CAGR of 15-18%. The company targets EBITDA margins in the 28-30% range over the medium term. The guidance reflects a dual focus on topline growth and profitability sustainability.

6 days ago
28Sep

Sai Life Sciences closes trading window from Oct 1 for Q2FY27 results

Trading window closed from October 1, 2026, for Q2FY27 results. Restriction applies to designated persons and immediate relatives. Window reopens 48 hours after financial results announcement. Board meeting date to be announced later.

1mo ago
17Sep

Sai Life Sciences shareholders approve FY26 results, re-appoint CEO

Sai Life Sciences shareholders adopted FY26 audited financial statements at the 27th AGM held on September 17, 2026. The re-appointment of Managing Director Krishnam Raju Kanumuri passed with 99.02% support, despite 1.82% dissent from public institutions. Promoter shareholders voted 100% in favour on both resolutions, holding 73.29 million shares. Total votes polled exceeded 189 million, with remote e-voting conducted via KFin Technologies.

2mo ago
4Sep

Sai Life Sciences to host investors at Jefferies forum on Sep 18

Sai Life Sciences hosts officials at Jefferies 5th India Forum. Meeting scheduled for September 18, 2026, in Gurugram. Sessions include group and one-on-one formats. Only publicly available information will be discussed.

2mo ago
4Sep

Sai Life Sciences to host investor meeting at Morgan Stanley conference

Sai Life Sciences to host investors at Morgan Stanley conference on September 14, 2026. Meetings will be held in New York from 9:00 am to 6:00 pm EST. Discussions limited to publicly available information only. Schedule subject to change based on participant exigencies.

2mo ago

Similar Stocks

StockLTPChange %Market Cap (Cr.)PE1Y Return
₹1,872.40+0.26%₹4,49,251.4840.80+6.56%
₹11,129.00+0.44%₹2,95,439.9887.70+70.91%
₹4,643.10-1.03%₹1,76,608.6085.00+21.17%
₹2,342.00+5.50%₹1,26,541.1289.90+134.43%
₹1,204.00+1.01%₹1,20,099.4627.60+27.48%
₹1,387.70+0.71%₹1,15,828.5841.80+11.37%
₹1,388.80-0.41%₹1,12,195.3839.50-9.35%
₹2,620.90-0.22%₹1,08,254.9947.90+15.61%
₹1,794.50+0.03%₹1,03,251.5625.80+46.79%
₹1,950.60-1.32%₹89,198.9817.30-5.09%
₹2,611.20-0.82%₹73,694.5151.10+37.75%
₹5,177.00+0.80%₹61,898.8029.40-9.53%